Natasha M. Kablaoui - Publications

Affiliations: 
Pfizer, Cambridge, MA 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sciabola S, Goetz GH, Bai G, Rogers BN, Gray DL, Duplantier A, Fonseca KR, Vanase-Frawley MA, Kablaoui NM. Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network. Bioorganic & Medicinal Chemistry. PMID 27297999 DOI: 10.1016/j.bmc.2016.05.062  0.6
2013 Walker DP, Arhancet GB, Lu HF, Heasley SE, Metz S, Kablaoui NM, Franco FM, Hanau CE, Scholten JA, Springer JR, Fobian YM, Carter JS, Xing L, Yang S, Shaffer AF, et al. Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound design. Bioorganic & Medicinal Chemistry Letters. 23: 1120-6. PMID 23298810 DOI: 10.1016/j.bmcl.2012.11.107  0.6
2011 Ye P, Kuhn C, Juan M, Sharma R, Connolly B, Alton G, Liu H, Stanton R, Kablaoui NM. Potent and selective thiophene urea-templated inhibitors of S6K. Bioorganic & Medicinal Chemistry Letters. 21: 849-52. PMID 21185721 DOI: 10.1016/j.bmcl.2010.11.069  0.6
2010 Patel SD, Habeski WM, Cheng AC, Cruz Edl, Loh C, Kablaoui NM. Corrigendum to "Quinazolin-4-piperidin-4-methyl sulfamide PC-1 inhibitors: Alleviating hERG interactions through structure based design" [Bioorg. Med. Chem. Lett. 19 (2009) 3339] (DOI:10.1016/j.bmcl.2009.04.006) Bioorganic and Medicinal Chemistry Letters. 20: 2685. DOI: 10.1016/j.bmcl.2010.01.024  0.6
2009 Patel SD, Habeski WM, Cheng AC, de la Cruz E, Loh C, Kablaoui NM. Quinazolin-4-piperidin-4-methyl sulfamide PC-1 inhibitors: alleviating hERG interactions through structure based design. Bioorganic & Medicinal Chemistry Letters. 19: 3339-43. PMID 19435660 DOI: 10.1016/j.bmcl.2009.04.006  0.6
2008 Patel SD, Habeski WM, Min H, Zhang J, Roof R, Snyder B, Bora G, Campbell B, Li C, Hidayetoglu D, Johnson DS, Chaudhry A, Charlton ME, Kablaoui NM. Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 18: 5689-93. PMID 18799310 DOI: 10.1016/j.bmcl.2008.08.055  0.6
1999 Hicks FA, Kablaoui NM, Buchwald SL. Scope of the intramolecular titanocene-catalyzed Pauson-Khand type reaction Journal of the American Chemical Society. 121: 5881-5898. DOI: 10.1021/ja990682u  1
1999 Sturla SJ, Kablaoui NM, Buchwald SL. A titanocene-catalyzed intramolecular ene reaction: Cycloisomerization of enynes and dienynes [12] Journal of the American Chemical Society. 121: 1976-1977. DOI: 10.1021/ja9839567  1
1997 Kablaoui NM, Hicks FA, Buchwald SL. Titanocene-catalyzed cyclocarbonylation of o-allyl aryl ketones to γ- butyrolactones Journal of the American Chemical Society. 119: 4424-4431. DOI: 10.1021/ja970115b  1
1996 Hicks FA, Kablaoui NM, Buchwald SL. Titanocene-catalyzed cyclocarbonylation of enynes to cyclopentenones Journal of the American Chemical Society. 118: 9450-9451. DOI: 10.1021/ja9621509  1
1996 Kablaoui NM, Hicks FA, Buchwald SL. Diastereoselective synthesis of γ-butryrolactones from enones mediated or catalyzed by a titanocene complex Journal of the American Chemical Society. 118: 5818-5819. DOI: 10.1021/ja960953q  1
1996 Kablaoui NM, Buchwald SL. Development of a method for the reductive cyclization of enones by a titanium catalyst Journal of the American Chemical Society. 118: 3182-3191. DOI: 10.1021/ja954192n  1
1995 Kablaoui NM, Buchwald SL. Reductive cyclization of enones by a titanium catalyst Journal of the American Chemical Society. 117: 6785-6786.  1
Show low-probability matches.